Just a moment, the page is loading...

*EISAI-E7080-G000-201




Phase II, Multicenter, Open-label, Single Arm Trial to Evaluate the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
lenvatinib
E7080-G000-201
NCT00784303
EU CTR 2007-005933-12
Thyroid Cancer
Phase 2
 
No restrictions.
August 2015